Automating Peptide Metabolite Identification: Realizing Speed and Precision with TidesID Platform by WuXi AppTec DMPK
(YorkPedia Editorial):- San Diego, California Sep 23, 2026 (Issuewire.com) – Peptide drugs exhibit unparalleled advantages in targeting “undruggable” protein-protein interactions. However, unmodified peptides naturally suffer from poor physiological stability and are rapidly cleaved by endopeptidases and exopeptidases circulating within the liver, kidney, blood, and gastrointestinal barriers. To improve druggability, developers deploy cyclic architectures and non-natural amino acid modifications. Consequently, executing rigorous peptide metabolite identification (MetID) becomes a critical regulatory milestone to uncover vulnerabilities early, continuously optimize molecular structures, and assess potential clinical safety risks. When pharmaceutical executives seek a CRO for peptide metabolite…
Read More